Crosstalk between plasma membrane and Staphylococcus α-hemolysin during oligomerization

Arnab Chatterjee,Anupam Roy,Thejas Satheesh,Debajyoti Chakraborty,Partho Pratim Das,Bapan Mondal,Prithiv Kishore,Bartika Ghoshal,Siddharth Jhunjhunwala,Mahipal Ganji,Somnath Dutta
DOI: https://doi.org/10.1101/2024.05.11.593496
2024-05-13
Abstract:The infectious microbe Staphylococcus aureus releases an array of cytotoxic pore-forming toxins (PFTs) that severely damage the cell membrane during bacterial infection. However, the interaction interfaces between the host cell and toxin were merely explored. Herein, we monitored the active oligomeric states facilitated membrane disruption processes such as lysis, and protrusion in the plasma membrane and lipid membrane. Furthermore, necrosis was triggered in the neutrophil-like cells upon synergistic binding and oligomerization of the monomeric α-HL. Additionally, we solved a RBC membrane stabilized structure of different conformational states of this β-PFT using a single-particle cryo-EM. We further confirmed that internal membrane fluidity was the deterministic factor associated with the formation of intermediate pre-pores, heptameric pore-like, and complete pore species. Together, this is the first study to unveil the structure-function analysis of pre-pore to pore transition of any small β-PFT during its crosstalk with the cell.
Biophysics
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: **To reveal the interaction mechanism between Staphylococcus aureus α - hemolysin (α - HL) and the host cell membrane during the oligomerization process**. Specifically, the research focuses on the following aspects: 1. **How α - HL promotes the deformation and damage of the host cell membrane**: The research experimentally observed the effects of α - HL on different cell types (such as red blood cells and neutrophil - like cells), and found that α - HL can cause phenomena such as cell membrane lysis and protrusion formation, and ultimately lead to cell necrosis. 2. **The oligomerization of α - HL on different lipid membranes and its influence**: By using artificial liposomes to simulate the cell membrane environment, the research explored the behavior of α - HL under different lipid compositions, especially the influence of lipid chain length on α - HL oligomerization and membrane damage. 3. **The structural characteristics of α - HL formed on the cell membrane**: Using single - particle cryo - electron microscopy (cryo - EM) technology, the research analyzed the different conformational states of α - HL on the red blood cell membrane (such as pre - pore, pore - like structures, etc.), and described in detail the molecular characteristics of these structures. 4. **The influence of lipid phase behavior on α - HL pore formation**: The research found that the fluidity of the lipid membrane (especially the ratio of the liquid - disordered phase Ld and the liquid - ordered phase Lo) significantly affects the α - HL pore formation process. By changing the phase behavior of the lipid membrane, the oligomerization and pore formation of α - HL can be regulated. ### Main findings - **α - HL promotes HL - 60 cell necrosis and the lysis of short lipid bilayer regions**. - **For the first time, the structure of small β - PFT in the cellular environment was analyzed by cryo - electron microscopy**. - **In the presence of red blood cells, the structural characteristics of the heptameric pore, pore - like structure and pre - pore complex were analyzed**. - **The phase behavior (Ld/Lo) of the lipid bilayer determines the different conformations and geometric variants of α - HL**. ### Research significance This research not only deeply reveals the specific mechanism of the interaction between α - HL and the host cell membrane, but also provides an important reference for understanding the pore - formation mechanisms of other similar small β - PFTs. In addition, the research results are helpful for developing new therapies against such toxins to reduce their damage to host cells.